Differential expressions of TLR9 have been observed between normal and tumor cells in various cancers, including head and neck cancer [53], B-cell chronic lymphocytic leukemia [13], colorectal cancer [54], and glioma [28]. This evidence concerns the gene TLR9 and B-cell chronic lymphocytic leukemia.